<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02299791</url>
  </required_header>
  <id_info>
    <org_study_id>1R18HL095481-01A1</org_study_id>
    <secondary_id>1R18HL095481-01A1</secondary_id>
    <nct_id>NCT02299791</nct_id>
  </id_info>
  <brief_title>Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics</brief_title>
  <acronym>ALL</acronym>
  <official_title>Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ochin, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Virginia Garcia Memorial Health Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Multnomah County Health Department</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the ALL Study is to determine the effectiveness of the dissemination of the
      ALL intervention from an integrated care setting into Community Health Centers (CHCs) by
      measuring changes in diabetes mellitus (DM) population prescription rates for the
      medications, using a pre-post comparison within clinics and a staggered, randomized
      implementation across clinics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ALL Initiative ('ALL') is a population-level management program developed at Kaiser
      Permanente (KP). It seeks to decrease cardiovascular disease (CVD) morbidity and mortality in
      patients with diabetes by improving rates of prescribing for guideline-concordant
      cardioprotective medications. Multiple mechanisms supported this intervention at KP. The
      investigators implemented ALL in 11 Community Health Centers (CHC) in the Portland, Oregon
      metropolitan area. To our knowledge, this was the first clinical trial testing the
      translation and implementation of a successful quality improvement (QI) initiative from a
      private, integrated care setting into CHCs.

      The investigators adapted the ALL intervention for CHCs through an iterative,
      stakeholder-driven process. The investigators then conducted a cluster-randomized pragmatic
      trial in 11 CHCs in a staggered process with six 'early' CHCs implementing the intervention
      one year before five 'late' CHCs. The investigators measured monthly rates of
      cardioprotective prescribing rates. Through segmented regression analysis, the investigators
      evaluated the intervention's effects in June 2011-May 2013. Participants included 11 CHCs
      serving ~6,500 adult patients with diabetes mellitus (DM) who were indicated for
      cardioprotective medications per national guidelines. The investigators also conducted a
      process evaluation to identify factors important to implementation success.

      Our overarching goals were to identify and resolve issues in disseminating a successful
      program from a large, well-organized health system into CHCs. The investigators hypothesized
      that cross-setting translation was feasible, and that adapting and implementing proven QI
      approaches could improve the care CHCs provide without requiring them to develop native
      initiatives. The investigators anticipated that this implementation would involve
      substantially adapting potentially 'translatable' practices and interventions, due to the
      differences between private, integrated care settings and CHCs in terms of patient needs and
      vulnerability, and system resources.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">May 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patients Indicated for ACE/ARB and Statin Who Had an Active Prescription for Both</measure>
    <time_frame>Percent of clinic patients prescribed guideline-concordant cardioprotective medications, as of the 1st day of each month, from up to 36 months</time_frame>
    <description>Number of patients indicated for ACE/ARB and statin who had an active prescription for both, as a proportion of patients indicated for ACE/ARB and statin.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4856</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Early Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6 study clinics received the ALL intervention starting 6/1/11</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late implementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5 study clinics received the ALL intervention starting 6/1/12</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ALL</intervention_name>
    <description>This clinic-level intervention involves a toolkit of decision support tools. These tools are listed below.
EHR tools to expedite identification
a. EHR automated point-of-care alerts (Best Practice Alerts)
EHR tools to expedite prescribing
EHR order sets
EHR text shortcuts for notation
patient education materials (handout, poster)
EHR-based outreach support tools a. EHR registries</description>
    <arm_group_label>Early Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ALL</intervention_name>
    <description>These clinics got the same exact intervention, but one year later, as this was a staggered randomized trial.</description>
    <arm_group_label>Late implementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Convenience sample of 11 community health clinics (CHCs) that are members of OCHIN,
             Inc.

        Exclusion Criteria:

          -  none, for study CHCs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rachel Gold, PhD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed?term=Collaborative%20development%20of%20a%20randomized%20study%20to%20adapt%20a%20diabetes%20quality%20improvement%20initiative%20for%20federally%20qualified%20health%20centers%5BTitle%5D</url>
    <description>PubMed</description>
  </link>
  <results_reference>
    <citation>Gold R, Muench J, Hill C, Turner A, Mital M, Milano C, Shah A, Nelson C, DeVoe JE, Nichols GA. Collaborative development of a randomized study to adapt a diabetes quality improvement initiative for federally qualified health centers. J Health Care Poor Underserved. 2012 Aug;23(3 Suppl):236-46. doi: 10.1353/hpu.2012.0132.</citation>
    <PMID>22864500</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 7, 2014</study_first_submitted>
  <study_first_submitted_qc>November 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <results_first_submitted>March 30, 2017</results_first_submitted>
  <results_first_submitted_qc>October 2, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">October 4, 2017</results_first_posted>
  <last_update_submitted>October 2, 2017</last_update_submitted>
  <last_update_submitted_qc>October 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>clinic-level interventions</keyword>
  <keyword>quality improvement</keyword>
  <keyword>translational medical research</keyword>
  <keyword>community health centers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment was done at the clinic level. All patients seen in the clinics were potentially eligible for the intervention based on clinic visit and clinical criteria.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Early Intervention Number of Patients</title>
          <description>Patients in 6 study clinics received the ALL intervention starting 6/1/11
ALL: This clinic-level intervention involves a toolkit of decision support tools. These tools are listed below.
EHR tools to expedite identification
a. EHR automated point-of-care alerts (Best Practice Alerts)
EHR tools to expedite prescribing
EHR order sets
EHR text shortcuts for notation
patient education materials (handout, poster)
EHR-based outreach support tools a. EHR registries</description>
        </group>
        <group group_id="P2">
          <title>Late Interventions Number of Patients</title>
          <description>5 study clinics received the ALL intervention starting 6/1/12
ALL: These clinics got the same exact intervention, but one year later, as this was a staggered randomized trial.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2053"/>
                <participants group_id="P2" count="2803"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2053"/>
                <participants group_id="P2" count="2803"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Early Intervention</title>
          <description>6 study clinics received the ALL intervention starting 6/1/11
ALL: This clinic-level intervention involves a toolkit of decision support tools. These tools are listed below.
EHR tools to expedite identification
a. EHR automated point-of-care alerts (Best Practice Alerts)
EHR tools to expedite prescribing
EHR order sets
EHR text shortcuts for notation
patient education materials (handout, poster)
EHR-based outreach support tools a. EHR registries</description>
        </group>
        <group group_id="B2">
          <title>Late Implementation</title>
          <description>5 study clinics received the ALL intervention starting 6/1/12
ALL: These clinics got the same exact intervention, but one year later, as this was a staggered randomized trial.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2053"/>
            <count group_id="B2" value="2803"/>
            <count group_id="B3" value="4856"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1518"/>
                    <measurement group_id="B2" value="2244"/>
                    <measurement group_id="B3" value="3762"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="535"/>
                    <measurement group_id="B2" value="559"/>
                    <measurement group_id="B3" value="1094"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" lower_limit="18" upper_limit="75"/>
                    <measurement group_id="B2" value="63" lower_limit="18" upper_limit="75"/>
                    <measurement group_id="B3" value="63" lower_limit="18" upper_limit="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1240"/>
                    <measurement group_id="B2" value="1634"/>
                    <measurement group_id="B3" value="2874"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="813"/>
                    <measurement group_id="B2" value="1169"/>
                    <measurement group_id="B3" value="1982"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="659"/>
                    <measurement group_id="B2" value="900"/>
                    <measurement group_id="B3" value="1559"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1374"/>
                    <measurement group_id="B2" value="1877"/>
                    <measurement group_id="B3" value="3251"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                    <measurement group_id="B2" value="138"/>
                    <measurement group_id="B3" value="239"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="179"/>
                    <measurement group_id="B2" value="244"/>
                    <measurement group_id="B3" value="423"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1258"/>
                    <measurement group_id="B2" value="1717"/>
                    <measurement group_id="B3" value="2975"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="485"/>
                    <measurement group_id="B2" value="663"/>
                    <measurement group_id="B3" value="1148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2053"/>
                    <measurement group_id="B2" value="2803"/>
                    <measurement group_id="B3" value="4856"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patients Indicated for ACE/ARB and Statin Who Had an Active Prescription for Both</title>
        <description>Number of patients indicated for ACE/ARB and statin who had an active prescription for both, as a proportion of patients indicated for ACE/ARB and statin.</description>
        <time_frame>Percent of clinic patients prescribed guideline-concordant cardioprotective medications, as of the 1st day of each month, from up to 36 months</time_frame>
        <population>clinic patients with diabetes who had a clinic encounter (in person or by telephone) within the previous year and were indicated for ACE/ARB and statin per current national care guidelines</population>
        <group_list>
          <group group_id="O1">
            <title>Early Intervention</title>
            <description>6 study clinics received the ALL intervention starting 6/1/11
ALL: This clinic-level intervention involves a toolkit of decision support tools. These tools are listed below.
EHR tools to expedite identification
a. EHR automated point-of-care alerts (Best Practice Alerts)
EHR tools to expedite prescribing
EHR order sets
EHR text shortcuts for notation
patient education materials (handout, poster)
EHR-based outreach support tools a. EHR registries</description>
          </group>
          <group group_id="O2">
            <title>Late Implementation</title>
            <description>5 study clinics received the ALL intervention starting 6/1/12
ALL: These clinics got the same exact intervention, but one year later, as this was a staggered randomized trial.</description>
          </group>
        </group_list>
        <measure>
          <title>Patients Indicated for ACE/ARB and Statin Who Had an Active Prescription for Both</title>
          <description>Number of patients indicated for ACE/ARB and statin who had an active prescription for both, as a proportion of patients indicated for ACE/ARB and statin.</description>
          <population>clinic patients with diabetes who had a clinic encounter (in person or by telephone) within the previous year and were indicated for ACE/ARB and statin per current national care guidelines</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2053"/>
                <count group_id="O2" value="2803"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1279"/>
                    <measurement group_id="O2" value="1318"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were not monitored for this cluster randomized trial.</time_frame>
      <desc>Adverse events were not monitored for this cluster randomized trial.</desc>
      <group_list>
        <group group_id="E1">
          <title>Early Intervention</title>
          <description>6 study clinics received the ALL intervention starting 6/1/11
ALL: This clinic-level intervention involves a toolkit of decision support tools. These tools are listed below.
EHR tools to expedite identification
a. EHR automated point-of-care alerts (Best Practice Alerts)
EHR tools to expedite prescribing
EHR order sets
EHR text shortcuts for notation
patient education materials (handout, poster)
EHR-based outreach support tools a. EHR registries</description>
        </group>
        <group group_id="E2">
          <title>Late Implementation</title>
          <description>5 study clinics received the ALL intervention starting 6/1/12
ALL: These clinics got the same exact intervention, but one year later, as this was a staggered randomized trial.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Rachel Gold</name_or_title>
      <organization>KaiserPermanente Center for Health Research</organization>
      <phone>503-528-3902</phone>
      <email>rachel.gold@kpchr.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

